全文获取类型
收费全文 | 1711篇 |
免费 | 111篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 138篇 |
妇产科学 | 13篇 |
基础医学 | 189篇 |
口腔科学 | 49篇 |
临床医学 | 168篇 |
内科学 | 542篇 |
皮肤病学 | 14篇 |
神经病学 | 86篇 |
特种医学 | 256篇 |
外科学 | 112篇 |
综合类 | 20篇 |
预防医学 | 92篇 |
眼科学 | 14篇 |
药学 | 56篇 |
肿瘤学 | 99篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 7篇 |
2020年 | 4篇 |
2019年 | 9篇 |
2018年 | 23篇 |
2017年 | 15篇 |
2016年 | 31篇 |
2015年 | 18篇 |
2014年 | 31篇 |
2013年 | 29篇 |
2012年 | 51篇 |
2011年 | 46篇 |
2010年 | 48篇 |
2009年 | 39篇 |
2008年 | 35篇 |
2007年 | 67篇 |
2006年 | 69篇 |
2005年 | 63篇 |
2004年 | 57篇 |
2003年 | 58篇 |
2002年 | 38篇 |
2001年 | 52篇 |
2000年 | 43篇 |
1999年 | 46篇 |
1998年 | 76篇 |
1997年 | 84篇 |
1996年 | 89篇 |
1995年 | 56篇 |
1994年 | 50篇 |
1993年 | 52篇 |
1992年 | 38篇 |
1991年 | 30篇 |
1990年 | 46篇 |
1989年 | 61篇 |
1988年 | 63篇 |
1987年 | 52篇 |
1986年 | 67篇 |
1985年 | 48篇 |
1984年 | 29篇 |
1983年 | 28篇 |
1982年 | 18篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 13篇 |
1978年 | 4篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1950年 | 1篇 |
排序方式: 共有1850条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
6.
Brenda M Sandmaier Storb Rainer Yanfang Liu Erlinda B Santos Eileen Bryant Friedrich G Schuening H Joachim Deeg Kristy Seidel Theodore Graham 《Transplant immunology》1996,4(4):271-274
920 cGy total body irradiation (TBI) is adequate for consistently successful engraftment of marrow from dog leukocyte antigen (DLA)-identical littermates; however, the dose is inadequate to ensure a marrow graft from DLA-nonidentical unrelated donors. Such mismatched grafts are successful only after 1800 cGy, given in three fractions. While anti-T-cell reagents enhance engraftment of DLA-identical littermate marrow after 920 cGy, they fail to be effective in the DLA-nonidentical setting. However, a monoclonal antibody (mAb) to CD44, S5, was found to be very effective in enhancing engraftment of DLA-nonidentical marrow. The current study asked whether mAb S5 was also effective in the setting of DLA-identical littermate transplants. To this purpose, the TBI dose was lowered to 450 cGy, a dose after which 70% of such grafts failed. Four dogs were treated with antibody S5, 0.2 mg/kg on days −7 though −2 (per previously published protocol), given 450 cGy TBI followed by marrow grafts from their DLA-identical littermates. All four dogs rejected their grafts; two of these died from marrow aplasia, and two survived with endogenous marrow recovery. This result was not statistically significantly different from that in 17, historical (n = 5) and concurrent (n = 12), control dogs where 11 of 17 animals rejected. Even if ten experimental animals were transplanted and all six remaining dogs engrafted, the results still would not have been significantly different from control. This result is in contrast to the successful engraftment promoted by pretreatment with antibody S5 of DLA-nonidentical unrelated dogs, consistent with the notion that different host cells are involved in graft rejection in the two disparate histocompatibility settings. 相似文献
7.
8.
9.
10.